Cuero Diabetes Support Group

03/16/2026

03/16/2026

Researchers led by Douglas Hanahan at the Swiss Federal Institute of Technology Lausanne (EPFL) studied whether existing drugs could affect glioblastoma, an aggressive brain cancer. They found that combining the antidepressant Imipramine with the blood thinner Ticlopidine caused tumor cells to undergo excessive autophagy, a cellular recycling process.

In mice with early-stage human glioblastoma, this drug combination forced cancer cells into lethal autophagy, meaning the cells broke down their own essential components and died. The treatment delayed tumor progression and roughly doubled the lifespan of the mice, although it did not cure the disease. Researchers emphasized that the findings are from animal studies and require further research before being considered for human treatment.

03/16/2026

✨🔬 American researchers cured re**al cancer completely without surgery or chemotherapy. Every single patient in the trial achieved 100% remission using dostarlimab, a checkpoint inhibitor drug that unmasks cancer cells so the immune system destroys them. No tumors remained, no follow-up treatment needed, and the study's perfection rate is unprecedented in oncology history.

Cancer cells hide from immune surveillance by expressing proteins that say "don't attack me" to T-cells. Dostarlimab blocks these deceptive signals, specifically targeting PD-1 receptors, allowing the body's natural defenses to recognize and eliminate malignant cells. For mismatch repair deficient re**al cancer, this approach worked flawlessly in every participant. No side effects beyond mild immune responses. No disfiguring surgeries. No toxic chemotherapy destroying healthy tissue.

This proves cancer isn't always invincible, sometimes it just needs the right key to unlock the immune system's full potential. Patients avoided life-altering colostomy bags, sexual dysfunction, and bowel control issues from surgery. They kept their quality of life while achieving complete cancer elimination. Pharmaceutical companies are now testing this approach on dozens of other cancer types with promising early results.

The frustrating part? Insurance companies resist covering it, claiming more evidence is needed despite perfect trial results. A one-time cure conflicts with their business model of managing chronic illness profitably. Medical innovation is racing ahead while insurance bureaucracy protects profits over lives.

Source: Memorial Sloan Kettering Cancer Center, New England Journal of Medicine 2025

What are your thoughts on the potential of immunotherapy? Does the gap between medical breakthroughs and insurance coverage concern you?

For educational purposes. This content is based on publicly available scientific research.

03/16/2026

Most people eat tomatoes and avocados separately—but combining them can unlock a powerful nutrition boost. Tomatoes are rich in lycopene, a potent antioxidant linked to lower risk of certain cancers and heart disease. However, lycopene is fat-soluble, which means your body absorbs it much better when it’s eaten with healthy fats. Avocados are packed with heart-healthy monounsaturated fats that help your body absorb lycopene far more efficiently. Studies have shown that adding avocado or other healthy fats to tomato-based foods can increase lycopene absorption by several times compared to eating tomatoes alone. This simple food pairing turns a regular salad into a smarter, more powerful nutrient combo for your body. Sometimes the secret to better nutrition isn’t eating more food—it’s combining the right foods together.

03/13/2026

03/13/2026

03/11/2026

03/10/2026